标题
The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2015, Issue -, Pages 1-11
出版商
Hindawi Limited
发表日期
2015-10-13
DOI
10.1155/2015/648090
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- JAK1/2 inhibition impairs T cell functionin vitroand in patients with myeloproliferative neoplasms
- (2015) Sowmya Parampalli Yajnanarayana et al. BRITISH JOURNAL OF HAEMATOLOGY
- JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells
- (2015) Clodagh Keohane et al. BRITISH JOURNAL OF HAEMATOLOGY
- Dynamics ofJAK2V617F allele burden of CD34+haematopoietic progenitor cells in patients treated with ruxolitinib
- (2015) Anna Angona et al. BRITISH JOURNAL OF HAEMATOLOGY
- The germline mutations of theCHEK2gene are associated with an increased risk of polycythaemia vera
- (2015) Hanna Janiszewska et al. BRITISH JOURNAL OF HAEMATOLOGY
- COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link
- (2015) Steven Bozinovski et al. BRITISH JOURNAL OF PHARMACOLOGY
- JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
- (2015) Kathrin Schönberg et al. CANCER RESEARCH
- Molecular diagnostics of myeloproliferative neoplasms
- (2015) Stephen E. Langabeer et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Regulation of catalase expression in healthy and cancerous cells
- (2015) Christophe Glorieux et al. FREE RADICAL BIOLOGY AND MEDICINE
- Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
- (2015) S. Verstovsek et al. HAEMATOLOGICA
- Oxidative Stress Response in Patients Infected by Diverse Hepatitis C Virus Genotypes
- (2015) Mohammad Hassan Khadem Ansari et al. Hepatitis Monthly
- Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial
- (2015) C. Conrad et al. Journal of Cystic Fibrosis
- Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera
- (2015) Cecilie Utke Rank et al. LEUKEMIA & LYMPHOMA
- JAK-STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
- (2015) M. Kleppe et al. Cancer Discovery
- Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
- (2015) S. Verstovsek et al. HAEMATOLOGICA
- Ruxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallenge
- (2014) Francesca Palandri et al. ANNALS OF HEMATOLOGY
- Leukemic transformation in myeloproliferative neoplasms: Therapy-related or unrelated?
- (2014) Magnus Björkholm et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
- (2014) A. Tefferi et al. BLOOD
- Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
- (2014) P. Lundberg et al. BLOOD
- From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms
- (2014) M. Cazzola et al. BLOOD
- Oxidative Stress and Respiratory System: Pharmacological and Clinical Reappraisal of N-Acetylcysteine
- (2014) Pierachille Santus et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state
- (2014) Mads Emil Bjørn et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Expansion of circulating CD56brightnatural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α
- (2014) Caroline H. Riley et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Disseminated tuberculosis associated with ruxolitinib
- (2014) R K Hopman et al. LEUKEMIA
- Ruxolitinib and survival improvement in patients with myelofibrosis
- (2014) F Passamonti et al. LEUKEMIA
- An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
- (2014) A Tefferi et al. LEUKEMIA
- Pulmonary tuberculosis reactivation following ruxolitinib treatment in a patient with primary myelofibrosis
- (2014) Yen-Hao Chen et al. LEUKEMIA & LYMPHOMA
- Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat
- (2014) Christen Lykkegaard Andersen et al. LEUKEMIA RESEARCH
- The effects of N-acetyl-cysteine and acetyl-l-carnitine on neural survival, neuroinflammation and regeneration following spinal cord injury
- (2014) A. Karalija et al. NEUROSCIENCE
- Interferon Alfa Therapy in CALR-Mutated Essential Thrombocythemia
- (2014) Bruno Cassinat et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole Blood Transcriptional Profiling Reveals Deregulation of Oxidative and Antioxidative Defence Genes in Myelofibrosis and Related Neoplasms. Potential Implications of Downregulation of Nrf2 for Genomic Instability and Disease Progression
- (2014) Hans Carl Hasselbalch et al. PLoS One
- Perspectives on the impact of JAK-inhibitor therapy upon inflammation-mediated comorbidities in myelofibrosis and related neoplasms
- (2014) Hans C Hasselbalch Expert Review of Hematology
- An Immune Dysregulation in MPN
- (2014) Giovanni Barosi Current Hematologic Malignancy Reports
- The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
- (2013) A. Heine et al. BLOOD
- Subcellular mislocalization of the transcription factor NF-E2 in erythroid cells discriminates prefibrotic primary myelofibrosis from essential thrombocythemia
- (2013) K. Aumann et al. BLOOD
- Ruxolitinib targets DCs: for better or worse?
- (2013) A. Tefferi BLOOD
- Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon- in a murine model of polycythemia vera
- (2013) A. Mullally et al. BLOOD
- JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFN
- (2013) S. Hasan et al. BLOOD
- Myeloproliferative neoplasms and thrombosis
- (2013) T. Barbui et al. BLOOD
- Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon -2a
- (2013) A. Quintas-Cardama et al. BLOOD
- Advanced Oxidation Protein Products Induce Inflammatory Response in Fibroblast-Like Synoviocytes through NADPH Oxidase -Dependent Activation of NF-κB
- (2013) Shuai Zheng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Polycythemia Vera Transforming to Myelofibrosis and then Biphenotype Acute Leukemia
- (2013) Xi-feng Dong et al. Clinical Laboratory
- Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose
- (2013) Lars E. Schmidt CLINICAL TOXICOLOGY
- Effect of High/Low Dose N-Acetylcysteine on Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
- (2013) Yanfei Shen et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- The role of cytokines in the initiation and progression of myelofibrosis
- (2013) Hans C. Hasselbalch CYTOKINE & GROWTH FACTOR REVIEWS
- Transcription factor nuclear factor erythroid-2 mediates expression of the cytokine interleukin 8, a known predictor of inferior outcome in patients with myeloproliferative neoplasms
- (2013) J. Wehrle et al. HAEMATOLOGICA
- Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation
- (2013) M. Hurtado-Nedelec et al. HAEMATOLOGICA
- Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2013) Ruben A. Mesa et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib
- (2013) M Massa et al. LEUKEMIA
- A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression
- (2013) C Marty et al. LEUKEMIA
- Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyurea
- (2013) Emma Verner et al. LEUKEMIA & LYMPHOMA
- Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis
- (2013) Vibe Skov et al. LEUKEMIA & LYMPHOMA
- The role of Janus kinase 2 (JAK2) in myeloproliferative neoplasms: Therapeutic implications
- (2013) Alfonso Quintás-Cardama LEUKEMIA RESEARCH
- Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha
- (2013) Thomas Stauffer Larsen et al. LEUKEMIA RESEARCH
- A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis?
- (2013) Hans C. Hasselbalch LEUKEMIA RESEARCH
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib
- (2013) Rowan Wathes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bilateral Toxoplasmosis Retinitis Associated with Ruxolitinib
- (2013) Roger A. Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidative Stress in Cardiovascular Diseases and Obesity: Role of p66Shc and Protein Kinase C
- (2013) Elena De Marchi et al. Oxidative Medicine and Cellular Longevity
- Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder
- (2013) Dan Xu et al. PLoS One
- HCV and Oxidative Stress in the Liver
- (2013) Alexander Ivanov et al. Viruses-Basel
- Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
- (2013) Richard T Silver et al. Expert Review of Hematology
- Acute Myeloid Leukemia Following a Myeloproliferative Neoplasm: Clinical Characteristics, Genetic Features and Effects of Therapy
- (2013) Mark L. Heaney et al. Current Hematologic Malignancy Reports
- Cutaneous ulcers associated with hydroxyurea therapy
- (2013) Filippo Quattrone et al. Journal of Tissue Viability
- Elevated Nuclear Factor Erythroid-2 Levels Promote Epo-Independent Erythroid Maturation and Recapitulate the Hematopoietic Stem Cell and Common Myeloid Progenitor Expansion Observed in Polycythemia Vera Patients
- (2013) Ruzhica Bogeska et al. Stem Cells Translational Medicine
- Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN
- (2012) Elisabetta Antonioli et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts
- (2012) Giorgio Trinchieri Annual Review of Immunology
- N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial
- (2012) Zhi-Wei Lai et al. ARTHRITIS AND RHEUMATISM
- Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
- (2012) H. C. Hasselbalch BLOOD
- Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls
- (2012) S. Verstovsek et al. BLOOD
- JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth
- (2012) Lori N. Griner et al. BRITISH JOURNAL OF HAEMATOLOGY
- Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives
- (2012) Hans Carl Hasselbalch et al. CURRENT DRUG TARGETS
- Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis
- (2012) Vibe Skov et al. EXPERIMENTAL HEMATOLOGY
- A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2
- (2012) Kai B. Kaufmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance
- (2012) Vibe Skov et al. LEUKEMIA RESEARCH
- Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
- (2012) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- (2012) Roberto Marchioli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuroprotective Effects of N-Acetyl-Cysteine and Acetyl-L-Carnitine after Spinal Cord Injury in Adult Rats
- (2012) Amar Karalija et al. PLoS One
- From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms
- (2012) Marion Martin et al. Genome Medicine
- Ruxolitinib for the treatment of myelofibrosis: its clinical potential
- (2012) Srdan Verstovsek et al. Therapeutics and Clinical Risk Management
- Singlet oxygen is essential for neutrophil extracellular trap formation
- (2011) Yoko Nishinaka et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells
- (2011) T. Yahata et al. BLOOD
- Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study
- (2011) H. Frederiksen et al. BLOOD
- The renaissance of interferon therapy for the treatment of myeloid malignancies
- (2011) J.-J. Kiladjian et al. BLOOD
- Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-
- (2011) C. H. Riley et al. BLOOD
- A dosing regimen for immediate N-acetylcysteine treatment for acute paracetamol overdose
- (2011) Finna Shen et al. CLINICAL TOXICOLOGY
- Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis
- (2011) Vibe Skov et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations
- (2011) H. Janiszewska et al. HAEMATOLOGICA
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Polycythemia Vera With Hydroxyurea and Pipobroman: Final Results of a Randomized Trial Initiated in 1980
- (2011) Jean-Jacques Kiladjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Nitric oxide and redox mechanisms in the immune response
- (2011) David A. Wink et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
- (2011) Alfonso Quintás-Cardama et al. NATURE REVIEWS DRUG DISCOVERY
- JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms
- (2011) M Nakatake et al. ONCOGENE
- Hepatocarcinogenesis in Hepatitis C: HCV Shrewdly Exacerbates Oxidative Stress by Modulating both Production and Scavenging of Reactive Oxygen Species
- (2011) Hidetake Fujinaga et al. ONCOLOGY
- A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms
- (2011) Hans Carl Hasselbalch Expert Review of Hematology
- Transformation of a Chronic Myeloproliferative Neoplasm to Acute Myelogenous Leukemia: Does Anything Work?
- (2011) Madappa N. Kundranda et al. Current Hematologic Malignancy Reports
- Current Treatment Concepts of Philadelphia-Negative MPN
- (2010) D. Wolf et al. CURRENT CANCER DRUG TARGETS
- ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− mice
- (2010) Safak Yalcin et al. EMBO JOURNAL
- Oxidative stress is increased in primary and post−polycythemia vera myelofibrosis
- (2010) Claudia Vener et al. EXPERIMENTAL HEMATOLOGY
- Hepatitis C Virus Regulates Transforming Growth Factor β1 Production Through the Generation of Reactive Oxygen Species in a Nuclear Factor κB–Dependent Manner
- (2010) Wenyu Lin et al. GASTROENTEROLOGY
- Autoimmunity and the risk of myeloproliferative neoplasms
- (2010) S. Y. Kristinsson et al. HAEMATOLOGICA
- Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
- (2010) T. Barbui et al. HAEMATOLOGICA
- Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
- (2010) A Tefferi LEUKEMIA
- Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
- (2010) Douglas B. Kuhns et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm
- (2009) P. A. Beer et al. BLOOD
- NF-E2 overexpression delays erythroid maturation and increases erythrocyte production
- (2009) Manuel Mutschler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chronic Granulomatous Disease
- (2009) Steven M. Holland CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Oxidative risk for atherothrombotic cardiovascular disease
- (2009) Jane A. Leopold et al. FREE RADICAL BIOLOGY AND MEDICINE
- Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission
- (2009) Thomas Stauffer Larsen et al. Hematology
- CHEK2 mutations and HNPCC-related colorectal cancer
- (2009) Janina Suchy et al. INTERNATIONAL JOURNAL OF CANCER
- Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
- (2009) Alfonso Quintás-Cardama et al. JOURNAL OF CLINICAL ONCOLOGY
- Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera
- (2008) T. S. Larsen et al. ANNALS OF HEMATOLOGY
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence
- (2008) J.-J. Lataillade et al. BLOOD
- Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders
- (2008) Daniela Capello et al. BRITISH JOURNAL OF HAEMATOLOGY
- Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders
- (2008) N. Fourouclas et al. HAEMATOLOGICA
- From inflammation to sickness and depression: when the immune system subjugates the brain
- (2007) Robert Dantzer et al. NATURE REVIEWS NEUROSCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started